Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Kymera Therapeutics First Quarter 2024 Results Conference Call. All participants will be in the listen-only mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Baker Bros. Advisors Julian Baker And Felix Baker | 5,995,928 | $241,036,306 | 3.02% | |
2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 5,161,801 | $207,504,400 | 5.7% | |
3. | VenBio Select Advisor Kurt Von Emster | 3,888,888 | $156,333,298 | +4% | 1.82% |
4. | Redmile Group Jeremy Green | 1,734,089 | $69,710,378 | -5% | 2.55% |
5. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 1,522,238 | $61,193,968 | 1.55% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$14.07 | 10,106 | Director, Other | 294,632 | 2023-11-03 | Filing | |
$14.07 | 83,708 | Director, Other | 2,104,075 | 2023-11-03 | Filing | |
$14.07 | 103,885 | Director, Other | 2,656,191 | 2023-11-03 | Filing | |
$11.64 | 26,772 | Director, Other | 284,526 | 2023-11-02 | Filing | |
$11.64 | 132,016 | Director, Other | 2,020,367 | 2023-11-02 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$46.10 | 9,864 | 95,470 | 2024-07-16 | Filing | ||
$45.59 | 13,281 | 105,604 | 2024-07-16 | Filing | ||
$45.15 | 16,455 | 95,740 | 2024-07-15 | Filing | ||
$39.26 | 20,238 | 723,246 | 2024-07-09 | Filing | ||
$38.48 | 38,606 | 743,484 | 2024-07-09 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 5,858,262 | $149,151,351 | 17.76% | |
2. | 4,815,558 | $122,604,107 | 0.02% | |
3. | 3,997,564 | $101,777,980 | 0% | |
4. | 3,566,611 | $90,805,915 | 0% | |
5. | 1,894,279 | $48,228,343 | 0% |